Ciphergen, Univ College of London, and UCL BioMedica Sign Collaboration Agreement to Validate and Discover New Biomarkers for Breast and Ovarian Cancer
6th Oct 2005, 17:52 GMT
Ciphergen and UCL Will Utilize Clinical Samples Collected in Large Scale Studies of Ovarian Cancer
Ciphergen, Univ College of London, and UCL BioMedica Sign Collaboration Agreement to Validate and Discover New Biomarkers for Breast and Ovarian Cancer related news:
- Ciphergen, University College of London, and UCL BioMedica Plc. Sign Collaboration Agreement to Validate and Discover New Biomarkers for Breast and Ovarian Cancer — PR Newswire: All Releases
- Familial Breast Cancer Doesn't Always Boost Ovarian Cancer Risk (HealthDay) — Yahoo! Health: Breast Cancer News
- UCL conference to launch global health institute — EurekAlert! - Social and Behavioral Science
- Newly Discovered Gene May Predict Aggressive Ovarian Cancer — ScienceDaily Headlines: Health & Medicine
- 9 mln Gift From Entertainment Industry Backs Effort to Develop Blood Test for Early Detection of Breast Cancer — Mammography News from StratCenter.com
- Beating breast cancer - October is Breast Cancer Awareness Month — Medical News Today RSS/XML Feed
- Breast cancer campaign launched — HEALTH
- /R E P E A T/ - October is Breast Cancer Awareness Month - One woman in nine will develop breast cancer in her lifetime. One in 27 will die from it — ArriveNet : Press Releases
- My Personal Journey With Breast Cancer — Breast Cancer Chronicles
- Breast Cancer Death Rates Dropping (American Cancer Society) — Yahoo! Health: Breast Cancer News